<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_source=Chrome&amp;ff=20231206193943&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_source=Chrome&amp;ff=20231206193943&amp;utm_campaign=pubmed-2&amp;v=2.17.9.post6+86293ac&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Thu, 07 Dec 2023 00:39:45 +0000</lastbuilddate>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Female Patient Presenting With Increasing Pedal Edema</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38055286/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Dec 6. doi: 10.1001/jamacardio.2023.4495. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055286/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38055286</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4495>10.1001/jamacardio.2023.4495</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38055286</guid>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Vinesh Appadurai</dc:creator>
<dc:creator>Neela Thangada</dc:creator>
<dc:creator>Akhil Narang</dc:creator>
<dc:date>2023-12-06</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Female Patient Presenting With Increasing Pedal Edema</dc:title>
<dc:identifier>pmid:38055286</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4495</dc:identifier>
</item>
<item>
<title>Sudden ST-Segment Changes in a Critically Ill Patient</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38055285/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Dec 6. doi: 10.1001/jamacardio.2023.4490. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055285/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38055285</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4490>10.1001/jamacardio.2023.4490</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38055285</guid>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Jessica M Hong</dc:creator>
<dc:creator>Ching Zhu</dc:creator>
<dc:creator>Marcella C Press</dc:creator>
<dc:date>2023-12-06</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Sudden ST-Segment Changes in a Critically Ill Patient</dc:title>
<dc:identifier>pmid:38055285</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4490</dc:identifier>
</item>
<item>
<title>Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38055247/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Results of this cohort study suggest that PCE performed well overall but had poorer performance in both BM and WM participants compared with female participants regardless of race in the REGARDS cohort. Removal of race or the addition of SDOH did not improve model performance in any subgroup.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Dec 6. doi: 10.1001/jamacardio.2023.4520. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Use of race-specific risk prediction in clinical medicine is being questioned. Yet, the most commonly used prediction tool for atherosclerotic cardiovascular disease (ASCVD)-pooled cohort risk equations (PCEs)-uses race stratification.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To quantify the incremental value of race-specific PCEs and determine whether adding social determinants of health (SDOH) instead of race improves model performance.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: Included in this analysis were participants from the biracial Reasons for Geographic and Racial Differences in Stroke (REGARDS) prospective cohort study. Participants were aged 45 to 79 years, without ASCVD, and with low-density lipoprotein cholesterol level of 70 to 189 mg/dL or non-high-density lipoprotein cholesterol level of 100 to 219 mg/dL at baseline during the period of 2003 to 2007. Participants were followed up to 10 years for incident ASCVD, including myocardial infarction, coronary heart disease death, and fatal and nonfatal stroke. Study data were analyzed from July 2022 to February 2023.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOME/MEASURES: Discrimination (C statistic, Net Reclassification Index [NRI]), and calibration (plots, Nam D'Agostino test statistic comparing observed to predicted events) were assessed for the original PCE, then for a set of best-fit, race-stratified equations including the same variables as in the PCE (model C), best-fit equations without race stratification (model D), and best-fit equations without race stratification but including SDOH as covariates (model E).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: This study included 11 638 participants (mean [SD] age, 61.8 [8.3] years; 6764 female [58.1%]) from the REGARDS cohort. Across all strata (Black female, Black male, White female, and White male participants), C statistics did not change substantively compared with model C (Black female, 0.71; 95% CI, 0.68-0.75; Black male, 0.68; 95% CI, 0.64-0.73; White female, 0.77; 95% CI, 0.74-0.81; White male, 0.68; 95% CI, 0.64-0.71), in model D (Black female, 0.71; 95% CI, 0.67-0.75; Black male, 0.68; 95% CI, 0.63-0.72; White female, 0.76; 95% CI, 0.73-0.80; White male, 0.68; 95% CI, 0.65-0.71), or in model E (Black female, 0.72; 95% CI, 0.68-0.76; Black male, 0.68; 95% CI, 0.64-0.72; White female, 0.77; 95% CI, 0.74-0.80; White male, 0.68; 95% CI, 0.65-0.71). Comparing model D with E using the NRI showed a net percentage decline in the correct assignment to higher risk for male but not female individuals. The Nam D'Agostino test was not significant for all race-sex strata in each model series, indicating good calibration in all groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Results of this cohort study suggest that PCE performed well overall but had poorer performance in both BM and WM participants compared with female participants regardless of race in the REGARDS cohort. Removal of race or the addition of SDOH did not improve model performance in any subgroup.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055247/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38055247</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4520>10.1001/jamacardio.2023.4520</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38055247</guid>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Arnab K Ghosh</dc:creator>
<dc:creator>Sara Venkatraman</dc:creator>
<dc:creator>Michael G Nanna</dc:creator>
<dc:creator>Monika M Safford</dc:creator>
<dc:creator>Lisandro D Colantonio</dc:creator>
<dc:creator>Todd M Brown</dc:creator>
<dc:creator>Laura C Pinheiro</dc:creator>
<dc:creator>Eric D Peterson</dc:creator>
<dc:creator>Ann Marie Navar</dc:creator>
<dc:creator>Madeline R Sterling</dc:creator>
<dc:creator>Orysya Soroka</dc:creator>
<dc:creator>Musarrat Nahid</dc:creator>
<dc:creator>Samprit Banerjee</dc:creator>
<dc:creator>Parag Goyal</dc:creator>
<dc:date>2023-12-06</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification</dc:title>
<dc:identifier>pmid:38055247</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4520</dc:identifier>
</item>
<item>
<title>Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38055237/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS AND RELEVANCE: An intensive telemonitoring strategy applied in the vulnerable period after an HF admission was feasible, well-accepted, and increased scores of HF self-care but did not translate to reductions in NT-proBNP levels nor improvement in a composite hierarchical clinical outcome.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Dec 6. doi: 10.1001/jamacardio.2023.4501. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Readmissions after an index heart failure (HF) hospitalization are a major contemporary health care problem.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the feasibility and efficacy of an intensive telemonitoring strategy in the vulnerable period after an HF hospitalization.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted in 30 HF clinics in Brazil. Patients with left ventricular ejection fraction less than 40% and access to mobile phones were enrolled up to 30 days after an HF admission. Data were collected from July 2019 to July 2022.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTION: Participants were randomly assigned to a telemonitoring strategy or standard care. The telemonitoring group received 4 daily short message service text messages to optimize self-care, active engagement, and early intervention. Red flags based on feedback messages triggered automatic diuretic adjustment and/or a telephone call from the health care team.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary end point was change in N-terminal pro-brain natriuretic peptide (NT-proBNP) from baseline to 180 days. A hierarchical win-ratio analysis incorporating blindly adjudicated clinical events (cardiovascular deaths and HF hospitalization) and variation in NT-proBNP was also performed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of 699 included patients, 460 (65.8%) were male, and the mean (SD) age was 61.2 (14.5) years. A total of 352 patients were randomly assigned to the telemonitoring strategy and 347 to standard care. Satisfaction with the telemonitoring strategy was excellent (net promoting score at 180 days, 78.5). HF self-care increased significantly in the telemonitoring group compared with the standard care group (score difference at 30 days, -2.21; 95% CI, -3.67 to -0.74; P = .001; score difference at 180 days, -2.08; 95% CI, -3.59 to -0.57; P = .004). Variation of NT-proBNP was similar in the telemonitoring group compared with the standard care group (telemonitoring: baseline, 2593 pg/mL; 95% CI, 2314-2923; 180 days, 1313 pg/mL; 95% CI, 1117-1543; standard care: baseline, 2396 pg/mL; 95% CI, 2122-2721; 180 days, 1319 pg/mL; 95% CI, 1114-1564; ratio of change, 0.92; 95% CI, 0.77-1.11; P = .39). Hierarchical analysis of the composite outcome demonstrated a similar number of wins in both groups (telemonitoring, 49 883 of 122 144 comparisons [40.8%]; standard care, 48 034 of 122 144 comparisons [39.3%]; win ratio, 1.04; 95% CI, 0.86-1.26).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: An intensive telemonitoring strategy applied in the vulnerable period after an HF admission was feasible, well-accepted, and increased scores of HF self-care but did not translate to reductions in NT-proBNP levels nor improvement in a composite hierarchical clinical outcome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04062461.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055237/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38055237</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4501>10.1001/jamacardio.2023.4501</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38055237</guid>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Luis E Rohde</dc:creator>
<dc:creator>Marciane M Rover</dc:creator>
<dc:creator>Conrado R Hoffmann Filho</dc:creator>
<dc:creator>Eneida Rejane Rabelo-Silva</dc:creator>
<dc:creator>Odilson M Silvestre</dc:creator>
<dc:creator>Silvia M Martins</dc:creator>
<dc:creator>Luiz C S Passos</dc:creator>
<dc:creator>José A de Figueiredo Neto</dc:creator>
<dc:creator>Luiz C Danzmann</dc:creator>
<dc:creator>Fábio S Silveira</dc:creator>
<dc:creator>Cezar Eumann Mesas</dc:creator>
<dc:creator>Mauro E Hernandes</dc:creator>
<dc:creator>Lidia Z Moura</dc:creator>
<dc:creator>Marcus V Simões</dc:creator>
<dc:creator>Luiz E F Ritt</dc:creator>
<dc:creator>Fábio Akio Nishijuka</dc:creator>
<dc:creator>Eduardo G Bertoldi</dc:creator>
<dc:creator>Frederico T C Dall Orto</dc:creator>
<dc:creator>Ellen Hettwer Magedanz</dc:creator>
<dc:creator>Ricardo Mourilhe-Rocha</dc:creator>
<dc:creator>Miguel M Fernandes-Silva</dc:creator>
<dc:creator>Almir Sergio Ferraz</dc:creator>
<dc:creator>Pedro Schwartzmann</dc:creator>
<dc:creator>Fábio M de Castilho</dc:creator>
<dc:creator>Antonio Carlos Pereira Barretto</dc:creator>
<dc:creator>Edval Gomes Dos Santos Júnior</dc:creator>
<dc:creator>Paulo Roberto Nogueira</dc:creator>
<dc:creator>Manoel Canesin</dc:creator>
<dc:creator>Luis Beck-da-Silva</dc:creator>
<dc:creator>Maísa de Carvalho Silva</dc:creator>
<dc:creator>Mario Sergio Adolfi Júnior</dc:creator>
<dc:creator>Renato H N Santos</dc:creator>
<dc:creator>Amanda Ferreira</dc:creator>
<dc:creator>Danielle Pereira</dc:creator>
<dc:creator>Leticia Lopes</dc:creator>
<dc:creator>Flávia C S Kojima</dc:creator>
<dc:creator>Viviane Campos</dc:creator>
<dc:creator>Pedro G M de Barros E Silva</dc:creator>
<dc:creator>Mariana Blacher</dc:creator>
<dc:creator>Alexandre B Cavalcanti</dc:creator>
<dc:creator>Felix Ramires</dc:creator>
<dc:creator>MESSAGE-HF Investigators</dc:creator>
<dc:date>2023-12-06</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Multifaceted Strategy Based on Automated Text Messaging After a Recent Heart Failure Admission: The MESSAGE-HF Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:38055237</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4501</dc:identifier>
</item>
<item>
<title>Race, Racism, and Risk-Implications of Social Determinants of Health in Cardiovascular Disease Prediction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38055236/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Dec 6. doi: 10.1001/jamacardio.2023.4529. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38055236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38055236</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.4529>10.1001/jamacardio.2023.4529</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38055236</guid>
<pubDate>Wed, 06 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Sadiya S Khan</dc:creator>
<dc:creator>Clyde W Yancy</dc:creator>
<dc:date>2023-12-06</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Race, Racism, and Risk-Implications of Social Determinants of Health in Cardiovascular Disease Prediction</dc:title>
<dc:identifier>pmid:38055236</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.4529</dc:identifier>
</item>
<item>
<title>Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38052973/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Dec 5. doi: 10.1038/s41569-023-00974-z. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38052973/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38052973</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00974-z>10.1038/s41569-023-00974-z</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38052973</guid>
<pubDate>Tue, 05 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Mattia Galli</dc:creator>
<dc:creator>Giampaolo Niccoli</dc:creator>
<dc:creator>Gianluigi De Maria</dc:creator>
<dc:creator>Salvatore Brugaletta</dc:creator>
<dc:creator>Rocco A Montone</dc:creator>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Stefano Benenati</dc:creator>
<dc:creator>Giulia Magnani</dc:creator>
<dc:creator>Domenico D'Amario</dc:creator>
<dc:creator>Italo Porto</dc:creator>
<dc:creator>Francesco Burzotta</dc:creator>
<dc:creator>Antonio Abbate</dc:creator>
<dc:creator>Dominick J Angiolillo</dc:creator>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-12-05</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction</dc:title>
<dc:identifier>pmid:38052973</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00974-z</dc:identifier>
</item>
<item>
<title>The case for eliminating racial and ethnic cardiovascular disparities in the USA</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38052972/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Dec 5. doi: 10.1038/s41569-023-00971-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38052972/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38052972</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00971-2>10.1038/s41569-023-00971-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38052972</guid>
<pubDate>Tue, 05 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Keith C Ferdinand</dc:creator>
<dc:date>2023-12-05</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>The case for eliminating racial and ethnic cardiovascular disparities in the USA</dc:title>
<dc:identifier>pmid:38052972</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00971-2</dc:identifier>
</item>
<item>
<title>Base editing therapy corrects long QT syndrome in mice</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38052971/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Dec 5. doi: 10.1038/s41569-023-00977-w. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38052971/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38052971</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00977-w>10.1038/s41569-023-00977-w</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38052971</guid>
<pubDate>Tue, 05 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Irene Fernández-Ruiz</dc:creator>
<dc:date>2023-12-05</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Base editing therapy corrects long QT syndrome in mice</dc:title>
<dc:identifier>pmid:38052971</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00977-w</dc:identifier>
</item>
<item>
<title>Dissecting embryonic and extraembryonic lineage crosstalk with stem cell co-culture</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38052213/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>Embryogenesis necessitates harmonious coordination between embryonic and extraembryonic tissues. Although stem cells of both embryonic and extraembryonic origins have been generated, they are grown in different culture conditions. In this study, utilizing a unified culture condition that activates the FGF, TGF-β, and WNT pathways, we have successfully derived embryonic stem cells (FTW-ESCs), extraembryonic endoderm stem cells (FTW-XENs), and trophoblast stem cells (FTW-TSCs) from the three...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Nov 24:S0092-8674(23)01225-4. doi: 10.1016/j.cell.2023.11.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Embryogenesis necessitates harmonious coordination between embryonic and extraembryonic tissues. Although stem cells of both embryonic and extraembryonic origins have been generated, they are grown in different culture conditions. In this study, utilizing a unified culture condition that activates the FGF, TGF-β, and WNT pathways, we have successfully derived embryonic stem cells (FTW-ESCs), extraembryonic endoderm stem cells (FTW-XENs), and trophoblast stem cells (FTW-TSCs) from the three foundational tissues of mouse and cynomolgus monkey (Macaca fascicularis) blastocysts. This approach facilitates the co-culture of embryonic and extraembryonic stem cells, revealing a growth inhibition effect exerted by extraembryonic endoderm cells on pluripotent cells, partially through extracellular matrix signaling. Additionally, our cross-species analysis identified both shared and unique transcription factors and pathways regulating FTW-XENs. The embryonic and extraembryonic stem cell co-culture strategy offers promising avenues for developing more faithful embryo models and devising more developmentally pertinent differentiation protocols.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38052213/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38052213</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.11.008>10.1016/j.cell.2023.11.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38052213</guid>
<pubDate>Tue, 05 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Yulei Wei</dc:creator>
<dc:creator>E Zhang</dc:creator>
<dc:creator>Leqian Yu</dc:creator>
<dc:creator>Baiquan Ci</dc:creator>
<dc:creator>Masahiro Sakurai</dc:creator>
<dc:creator>Lei Guo</dc:creator>
<dc:creator>Xin Zhang</dc:creator>
<dc:creator>Sirui Lin</dc:creator>
<dc:creator>Shino Takii</dc:creator>
<dc:creator>Lizhong Liu</dc:creator>
<dc:creator>Jian Liu</dc:creator>
<dc:creator>Daniel A Schmitz</dc:creator>
<dc:creator>Ting Su</dc:creator>
<dc:creator>Junmei Zhang</dc:creator>
<dc:creator>Qiaoyan Shen</dc:creator>
<dc:creator>Yi Ding</dc:creator>
<dc:creator>Linfeng Zhan</dc:creator>
<dc:creator>Hai-Xi Sun</dc:creator>
<dc:creator>Canbin Zheng</dc:creator>
<dc:creator>Lin Xu</dc:creator>
<dc:creator>Daiji Okamura</dc:creator>
<dc:creator>Weizhi Ji</dc:creator>
<dc:creator>Tao Tan</dc:creator>
<dc:creator>Jun Wu</dc:creator>
<dc:date>2023-12-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Dissecting embryonic and extraembryonic lineage crosstalk with stem cell co-culture</dc:title>
<dc:identifier>pmid:38052213</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.11.008</dc:identifier>
</item>
<item>
<title>Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38048397/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 5;148(23):e186. doi: 10.1161/CIR.0000000000001195. Epub 2023 Dec 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38048397/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38048397</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001195>10.1161/CIR.0000000000001195</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38048397</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:38048397</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001195</dc:identifier>
</item>
<item>
<title>Response by Nademanee et al to Letter Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38048396/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 5;148(23):1915-1916. doi: 10.1161/CIRCULATIONAHA.123.066505. Epub 2023 Dec 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38048396/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38048396</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066505>10.1161/CIRCULATIONAHA.123.066505</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38048396</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Koonlawee Nademanee</dc:creator>
<dc:creator>Michel Haissaguerre</dc:creator>
<dc:creator>Arthur A M Wilde</dc:creator>
<dc:creator>Elijah Behr</dc:creator>
<dc:creator>Akihiko Nogami</dc:creator>
<dc:creator>BRAVO Investigators</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Nademanee et al to Letter Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)"</dc:title>
<dc:identifier>pmid:38048396</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066505</dc:identifier>
</item>
<item>
<title>ALPK3 Functions as a Pseudokinase</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38048395/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 5;148(23):1911-1913. doi: 10.1161/CIRCULATIONAHA.123.065993. Epub 2023 Dec 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38048395/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38048395</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10697696/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">PMC10697696</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065993>10.1161/CIRCULATIONAHA.123.065993</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38048395</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Wei Feng</dc:creator>
<dc:creator>Julius Bogomolovas</dc:creator>
<dc:creator>Li Wang</dc:creator>
<dc:creator>Mengchen Li</dc:creator>
<dc:creator>Ju Chen</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>ALPK3 Functions as a Pseudokinase</dc:title>
<dc:identifier>pmid:38048395</dc:identifier>
<dc:identifier>pmc:PMC10697696</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065993</dc:identifier>
</item>
<item>
<title>Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38048394/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 5;148(23):1914. doi: 10.1161/CIRCULATIONAHA.123.065320. Epub 2023 Dec 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38048394/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38048394</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065320>10.1161/CIRCULATIONAHA.123.065320</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38048394</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Naoya Kataoka</dc:creator>
<dc:creator>Teruhiko Imamura</dc:creator>
<dc:creator>Koichiro Kinugawa</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)"</dc:title>
<dc:identifier>pmid:38048394</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065320</dc:identifier>
</item>
<item>
<title>A Story With an Interesting Twist</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38048393/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 5;148(23):1907-1910. doi: 10.1161/CIRCULATIONAHA.123.067296. Epub 2023 Dec 4.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38048393/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38048393</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067296>10.1161/CIRCULATIONAHA.123.067296</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38048393</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Chan-Hee Lee</dc:creator>
<dc:creator>Melvin M Scheinman</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Story With an Interesting Twist</dc:title>
<dc:identifier>pmid:38048393</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067296</dc:identifier>
</item>
<item>
<title>Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38047387/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 4. doi: 10.1161/CIRCULATIONAHA.123.065530. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; <i>P</i>=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38047387/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38047387</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065530>10.1161/CIRCULATIONAHA.123.065530</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38047387</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>F Laguzzi</dc:creator>
<dc:creator>A Åkesson</dc:creator>
<dc:creator>M Marklund</dc:creator>
<dc:creator>F Qian</dc:creator>
<dc:creator>B Gigante</dc:creator>
<dc:creator>T M Bartz</dc:creator>
<dc:creator>J K Bassett</dc:creator>
<dc:creator>A Birukov</dc:creator>
<dc:creator>H Campos</dc:creator>
<dc:creator>Y Hirakawa</dc:creator>
<dc:creator>F Imamura</dc:creator>
<dc:creator>S Jäger</dc:creator>
<dc:creator>M Lankinen</dc:creator>
<dc:creator>R A Murphy</dc:creator>
<dc:creator>M Senn</dc:creator>
<dc:creator>T Tanaka</dc:creator>
<dc:creator>N Tintle</dc:creator>
<dc:creator>J K Virtanen</dc:creator>
<dc:creator>K Yamagishi</dc:creator>
<dc:creator>M Allison</dc:creator>
<dc:creator>I A Brouwer</dc:creator>
<dc:creator>U De Faire</dc:creator>
<dc:creator>G Eiriksdottir</dc:creator>
<dc:creator>L Ferrucci</dc:creator>
<dc:creator>N G Forouhi</dc:creator>
<dc:creator>J M Geleijnse</dc:creator>
<dc:creator>A M Hodge</dc:creator>
<dc:creator>H Kimura</dc:creator>
<dc:creator>M Laakso</dc:creator>
<dc:creator>U Risérus</dc:creator>
<dc:creator>A C van Westing</dc:creator>
<dc:creator>S Bandinelli</dc:creator>
<dc:creator>A Baylin</dc:creator>
<dc:creator>G G Giles</dc:creator>
<dc:creator>V Gudnason</dc:creator>
<dc:creator>H Iso</dc:creator>
<dc:creator>R N Lemaitre</dc:creator>
<dc:creator>T Ninomiya</dc:creator>
<dc:creator>W S Post</dc:creator>
<dc:creator>B M Psaty</dc:creator>
<dc:creator>J T Salonen</dc:creator>
<dc:creator>M B Schulze</dc:creator>
<dc:creator>M Y Tsai</dc:creator>
<dc:creator>M Uusitupa</dc:creator>
<dc:creator>N J Wareham</dc:creator>
<dc:creator>S W Oh</dc:creator>
<dc:creator>A C Wood</dc:creator>
<dc:creator>W S Harris</dc:creator>
<dc:creator>D Siscovick</dc:creator>
<dc:creator>D Mozaffarian</dc:creator>
<dc:creator>K Leander</dc:creator>
<dc:creator>Fatty Acids and Outcomes Research Consortium (FORCE)</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies</dc:title>
<dc:identifier>pmid:38047387</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065530</dc:identifier>
</item>
<item>
<title>CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38047378/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: LGMN deficiency in T cells prevents hypertension and its complications by promoting Treg differentiation and function. Specifically targeting LGMN in Tregs may be an innovative approach for hypertension treatment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Dec 4. doi: 10.1161/CIRCRESAHA.123.322835. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: T cells are central to the immune responses contributing to hypertension. LGMN (legumain) is highly expressed in T cells; however, its role in the pathogenesis of hypertension remains unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Peripheral blood samples were collected from patients with hypertension, and CD4+ T cells were sorted for gene expression and Western blotting analysis. TLGMNKO (T cell-specific LGMN-knockout) mice (Lgmn<sup>f/f</sup>/CD4<sup>Cre</sup>), regulatory T cell (Treg)-specific LGMN-knockout mice (Lgmn<sup>f/f</sup>/Foxp3<sup>YFP Cre</sup>), and RR-11a (LGMN inhibitor)-treated C57BL/6 mice were infused with Ang II (angiotensin II) or deoxycorticosterone acetate/salt to establish hypertensive animal models. Flow cytometry, 4-dimensional label-free proteomics, coimmunoprecipitation, Treg suppression, and in vivo Treg depletion or adoptive transfer were used to delineate the functional importance of T-cell LGMN in hypertension development.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: LGMN mRNA expression was increased in CD4+ T cells isolated from hypertensive patients and mice, was positively correlated with both systolic and diastolic blood pressure, and was negatively correlated with serum IL (interleukin)-10 levels. TLGMNKO mice exhibited reduced Ang II-induced or deoxycorticosterone acetate/salt-induced hypertension and target organ damage relative to WT (wild-type) mice. Genetic and pharmacological inhibition of LGMN blocked Ang II-induced or deoxycorticosterone acetate/salt-induced immunoinhibitory Treg reduction in the kidneys and blood. Anti-CD25 antibody depletion of Tregs abolished the protective effects against Ang II-induced hypertension in TLGMNKO mice, and LGMN deletion in Tregs prevented Ang II-induced hypertension in mice. Mechanistically, endogenous LGMN impaired Treg differentiation and function by directly interacting with and facilitating the degradation of TRAF6 (tumor necrosis factor receptor-associated factor 6) via chaperone-mediated autophagy, thereby inhibiting NF-κB (nuclear factor kappa B) activation. Adoptive transfer of LGMN-deficient Tregs reversed Ang II-induced hypertension, whereas depletion of TRAF6 in LGMN-deficient Tregs blocked the protective effects.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: LGMN deficiency in T cells prevents hypertension and its complications by promoting Treg differentiation and function. Specifically targeting LGMN in Tregs may be an innovative approach for hypertension treatment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38047378/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38047378</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322835>10.1161/CIRCRESAHA.123.322835</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38047378</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Yuhu He</dc:creator>
<dc:creator>Pu Zou</dc:creator>
<dc:creator>Junmi Lu</dc:creator>
<dc:creator>Yufei Lu</dc:creator>
<dc:creator>Shuguang Yuan</dc:creator>
<dc:creator>Xialei Zheng</dc:creator>
<dc:creator>Jing Liu</dc:creator>
<dc:creator>Cheng Zeng</dc:creator>
<dc:creator>Ling Liu</dc:creator>
<dc:creator>Liang Tang</dc:creator>
<dc:creator>Zhenfei Fang</dc:creator>
<dc:creator>Xinqun Hu</dc:creator>
<dc:creator>Qiming Liu</dc:creator>
<dc:creator>Shenghua Zhou</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6</dc:title>
<dc:identifier>pmid:38047378</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322835</dc:identifier>
</item>
<item>
<title>Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38047353/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Dec 4. doi: 10.1161/CIR.0000000000001187. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38047353/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38047353</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001187>10.1161/CIR.0000000000001187</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38047353</guid>
<pubDate>Mon, 04 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Larry M Baddour</dc:creator>
<dc:creator>Zerelda Esquer Garrigos</dc:creator>
<dc:creator>M Rizwan Sohail</dc:creator>
<dc:creator>Eva Havers-Borgersen</dc:creator>
<dc:creator>Andrew D Krahn</dc:creator>
<dc:creator>Vivian H Chu</dc:creator>
<dc:creator>Connie S Radke</dc:creator>
<dc:creator>Jennifer Avari-Silva</dc:creator>
<dc:creator>Mikhael F El-Chami</dc:creator>
<dc:creator>Jose M Miro</dc:creator>
<dc:creator>Daniel C DeSimone</dc:creator>
<dc:creator>American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young (Young Hearts); and Council on Clinical Cardiology</dc:creator>
<dc:date>2023-12-04</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38047353</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001187</dc:identifier>
</item>
<item>
<title>2023 Atrial Fibrillation Guideline-at-a-Glance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38043044/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)07853-1. doi: 10.1016/j.jacc.2023.10.021. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38043044/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38043044</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.021>10.1016/j.jacc.2023.10.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38043044</guid>
<pubDate>Sun, 03 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Barbara S Wiggins</dc:creator>
<dc:creator>ACC Solution Set Oversight Committee</dc:creator>
<dc:creator>Morgane Cibotti-Sun</dc:creator>
<dc:creator>Mykela M Moore</dc:creator>
<dc:date>2023-12-03</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2023 Atrial Fibrillation Guideline-at-a-Glance</dc:title>
<dc:identifier>pmid:38043044</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.021</dc:identifier>
</item>
<item>
<title>2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38043043/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>AIM: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STRUCTURE: Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" and the "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38043043/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38043043</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.08.017>10.1016/j.jacc.2023.08.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38043043</guid>
<pubDate>Sun, 03 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Writing Committee Members</dc:creator>
<dc:creator>José A Joglar</dc:creator>
<dc:creator>Mina K Chung</dc:creator>
<dc:creator>Anastasia L Armbruster</dc:creator>
<dc:creator>Emelia J Benjamin</dc:creator>
<dc:creator>Janice Y Chyou</dc:creator>
<dc:creator>Edmond M Cronin</dc:creator>
<dc:creator>Anita Deswal</dc:creator>
<dc:creator>Lee L Eckhardt</dc:creator>
<dc:creator>Zachary D Goldberger</dc:creator>
<dc:creator>Rakesh Gopinathannair</dc:creator>
<dc:creator>Bulent Gorenek</dc:creator>
<dc:creator>Paul L Hess</dc:creator>
<dc:creator>Mark Hlatky</dc:creator>
<dc:creator>Gail Hogan</dc:creator>
<dc:creator>Chinwe Ibeh</dc:creator>
<dc:creator>Julia H Indik</dc:creator>
<dc:creator>Kazuhiko Kido</dc:creator>
<dc:creator>Fred Kusumoto</dc:creator>
<dc:creator>Mark S Link</dc:creator>
<dc:creator>Kathleen T Linta</dc:creator>
<dc:creator>Gregory M Marcus</dc:creator>
<dc:creator>Patrick M McCarthy</dc:creator>
<dc:creator>Nimesh Patel</dc:creator>
<dc:creator>Kristen K Patton</dc:creator>
<dc:creator>Marco V Perez</dc:creator>
<dc:creator>Jonathan P Piccini</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Prashanthan Sanders</dc:creator>
<dc:creator>Megan M Streur</dc:creator>
<dc:creator>Kevin L Thomas</dc:creator>
<dc:creator>Sabrina Times</dc:creator>
<dc:creator>James E Tisdale</dc:creator>
<dc:creator>Anne Marie Valente</dc:creator>
<dc:creator>David R Van Wagoner</dc:creator>
<dc:date>2023-12-03</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:38043043</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.08.017</dc:identifier>
</item>
<item>
<title>New insights into dietary cholesterol absorption</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38040795/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2023 Dec 1. doi: 10.1038/s41569-023-00975-y. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38040795/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38040795</a> | DOI:<a href=https://doi.org/10.1038/s41569-023-00975-y>10.1038/s41569-023-00975-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38040795</guid>
<pubDate>Fri, 01 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Jennifer Harman</dc:creator>
<dc:date>2023-12-01</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>New insights into dietary cholesterol absorption</dc:title>
<dc:identifier>pmid:38040795</dc:identifier>
<dc:identifier>doi:10.1038/s41569-023-00975-y</dc:identifier>
</item>
<item>
<title>Cardiac imaging: focus on safety, optimal delivery, and risk stratification</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38038647/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20231206193943&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Dec 1;44(45):4725-4728. doi: 10.1093/eurheartj/ehad773.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38038647/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20231206193943&v=2.17.9.post6+86293ac">38038647</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad773>10.1093/eurheartj/ehad773</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38038647</guid>
<pubDate>Fri, 01 Dec 2023 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2023-12-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiac imaging: focus on safety, optimal delivery, and risk stratification</dc:title>
<dc:identifier>pmid:38038647</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad773</dc:identifier>
</item>





























</channel>
</rss>